Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Insulin prices

- PMLiVE

Novo Nordisk posts ‘robust’ gains in sales and earnings

Diabetes drug Victoza and insulin analogue portfolio see strong growth

- PMLiVE

Sanofi nearing end of patent cliff, says Viehbacher

Higher third-quarter revenues see pharma company raise forecasts for 2012

Genzyme enters $22.5m RNAi deal with Alnylam in Asia

Programme targets condition affecting heart and nervous system

- PMLiVE

Diabetes care recognised at UK awards

Joint working between pharma, NHS and patient organisations key among winners at QiC Diabetes 2012

- PMLiVE

Novo wins CHMP backing for Tresiba and diabetes first

EMA advisors recommend approval of once-daily at unique higher strength

- PMLiVE

FDA panel backs Sanofi’s Kynamro for high cholesterol

Recommendation comes despite safety concerns

- PMLiVE

Novo Nordisk files new haemophilia drug in EU, US

Seeks approval for turoctocog alfa shortly after vatreptacog alfa pulled

Study shows Sanofi’s Zaltrap effective in colorectal cancer

Reinforces prospects following US approval

- PMLiVE

Sanofi acquires Colombian pharma manufacturing firm Genfar

Expands its Latin American generics portfolio

- PMLiVE

Sanofi promotes diabetes expert Paul Chew to chief medical officer

Takes over from Jean-Pierre Lehner who retires

- PMLiVE

Novo drops late-stage haemophilia candidate vatreptacog alfa

Patients developed anti-drug antibodies during phase III clinical trial

- PMLiVE

Sanofi plans 900 job cuts in France in upheaval of research

Future of Toulouse site remains in balance

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links